<DOC>
	<DOCNO>NCT00202813</DOCNO>
	<brief_summary>This study help determine determine whether use antibiotic coat catheter significantly reduce number central line relate bloodstream infection child require CVC . This study may also determine antibiotic coated catheter significantly less likely non-antibiotic coat catheter allow bacteria live ( colonize ) in/on catheter . The use central venous catheter ( CVC ) paramount care critically ill child . Thus , pediatric intensive care unit ( PICU ) , catheter widely use situation peripheral venous access necessary . This central access allow delivery fluid , e.g , blood , medication , etc . well serve mean withdraw blood . It estimate 250,000 nosocomial bloodstream infection occur year , 90 % associate use CVCs . More recently , National Nosocomial Infection Surveillance System ( NNIS ) report 1992-2001 CVC-associated bloodstream infection ( BSI ) ICU setting occur rate 2.9-11.3 BSI per 1,000 catheter day . The cost treat CVC related BSI estimate excess $ 28,000 per catheter . In adult medical literature , strong evidence support use antiseptic antibiotic coat catheter reduce cost hospitalization CVC related infection . Cost-benefit study suggest baseline incidence CVC BSI &gt; 0.4 BSI per 1000 catheter day , $ 59,000 save , 7 case BSI avoid , 1 death prevent every 300 anti-septic impregnated CVCs use .</brief_summary>
	<brief_title>Study Use Coated Venous Catheters Critically Ill Child</brief_title>
	<detailed_description>Catheter related infection often difficult treat pathogen may form biofilm actually embed catheter material . Additionally , catheter hub skin around area may colonize bacteria . It route pathogenic organism migrate external surface catheter , progress intravascular tip . To decrease risk CVC associate infection , antibiotic coat catheter use . Since 1990 , several type antiseptic antimicrobial vascular catheter develop . These catheter design protect external internal surface device colonization certain bacteria . Raad et al , demonstrate randomized multicenter clinical trial among hospitalized adult patient CVCs coat minocycline rifampin significantly reduce risk catheter-related colonization bloodstream infection [ 8 ] . However , clinical trial report pediatric population issue . This study prospectively compare randomize , blind fashion use two Food &amp; Drug Administration ( FDA ) approve central venous catheter - antibiotic coated CVC non-coated CVC DeVos Children 's Hospital Spectrum Health , Grand Rapids , Michigan . Additional major pediatric teach hospital may add late time .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>patient age 21 year less admitted pediatric intensive care unit general pediatric unit DeVos Children 's Hospital research inform consent must sign know allergy sensitivity minocycline , tetracyline , doxycycline , oxytetracycline , demeclocycline , rifampin , rifabutin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>CVC</keyword>
	<keyword>central venous catheter</keyword>
	<keyword>infection</keyword>
	<keyword>bloodstream infection</keyword>
	<keyword>catheter infection</keyword>
	<keyword>pediatric</keyword>
	<keyword>child</keyword>
	<keyword>antibiotic impregnate catheter</keyword>
</DOC>